microdose glp 1 THE GLP-1 MICRODOSING PROGRAM How microdosing GLP-1 drugs became

Description

Saisho Y., An Emerging New Concept for the Management of Type 2 Diabetes With a Paradigm Shift From the GlucoseCentric to Beta CellCentric Concept of DiabetesAn Asian Perspective, Expert Opinion on Pharmacotherapy 21, no

But understanding this context helps set realistic expectations when marketing materials reference studies conducted at significantly higher dosages

( 10.3803/EnM.2022.1642) [DOI] [PMC free article] [PubMed] [Google Scholar] Wadden TA, Chao AM, Machineni S, Kushner R, Ard J, Srivastava G, Halpern B, Zhang S, Chen J, Bunck MC, et al

Accessed at utswmed.org/medblog/obesitymedication-weight-program

Despite showing an increase in SIBO likelihood, the numbers were minimal (fewer than 0.02%), and the study did not prove causation, only a correlation based on a yes/no diagnosis